Business Wire

NY-IMPACTWAYV

Share
ImpactWayv™ Completes Beta Test of Its Social Impact Media and Technology Platform and Announces Upcoming Public Launch

ImpactWayv, Inc. is pleased to announce it has recently concluded the private beta test of ImpactWayv ™, the company’s pioneering social impact media and technology networking platform that will launch publicly this spring. ImpactWayv connects people, businesses and philanthropy – for good.

Designed to be a healthier and more meaningful alternative to major social networking platforms, ImpactWayv is the next generation digital ecosystem where people, businesses and nonprofits engage to effect positive change and maximize social impact. ImpactWayv unites disparate sources of information, initiatives and innovations from across the global social good sector under one digital roof to generate greater and more efficient collective impact.

Reception to ImpactWayv’s invitation-only private beta test was overwhelmingly positive, with individual, business and nonprofit users confirming the strong need for this type of holistic social impact-focused platform within today’s social media landscape. Users were guided through ImpactWayv’s core user flow to validate design, functionality and usability. The results reinforced the platform’s underlying social impact thesis, focused on fostering universal social good through a continuous cycle of engagement, interaction and empowerment.

At a time of unprecedented interest in social action globally, ImpactWayv provides the social media network solution that addresses the convergence of three major trends in society:

  • People’s hunger for greater purpose and meaning in all aspects of life – family, friends, social interaction, employment, consumer relationships, investing, donating and volunteering.
  • Businesses’ imperative to demonstrate to all stakeholders and the world their social good efforts.
  • Nonprofits’ pressing need for global connectivity and adoption of private sector business and marketing principles, supporting sustainability and mission achievement.

“ImpactWayv is uniquely positioned for this moment in time,” said George Dolatly, Co-Founder and President of ImpactWayv, Inc. “Our groundbreaking platform creates the opportunity for people, businesses and nonprofits to work together efficiently and effectively on all fronts to maximize social good and positive change.”

ImpactWayv will also feature a digital “Social Impact as a Service” (SIaaS) offering to both businesses and nonprofits to best address emerging social impact trends such as business models that integrate the values and metrics of Environmental, Social & Governance (ESG) criteria, Corporate Social Responsibility (CSR) and the United Nations Sustainable Development Goals (SDGs). This will allow ImpactWayv to provide advisory and support services through a global team of social impact sector leaders, experts and experienced professionals.

“Our current climate has demonstrated just how motivated people are to come together to foster positive social change,” said Benji Bernstein, Co-Founder and Chief Technology Officer of ImpactWayv, Inc. “The time is now for a new digital ecosystem that meets this critical moment – a social media network created to unite and empower people, businesses and nonprofits for greater collective impact, via a continuous cycle of social good. ImpactWayv is that platform, a breakthrough force for good.”

About ImpactWayv, Inc.

ImpactWayv, Inc. is a social impact media and technology company, consisting of thought leaders and doers from across the business, nonprofit and technology sectors. ImpactWayv was created to disrupt and transform the worlds of business and philanthropy through technology – to advance universal social good. For more information or to be added to the ImpactWayv user list, please visit: www.ImpactWayv.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IFF and BASF Announce Strategic Collaboration to Drive Next-Generation Enzyme and Polymer Innovation21.10.2025 12:00:00 CEST | Press release

IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences — announced a strategic collaboration with BASF, one of the world’s largest chemical companies and leader in sustainable product innovation, to accelerate the development of IFF’s Designed Enzymatic Biomaterials™ technology platform and create next-generation enzyme technologies for fabric, dish and personal care as well as industrial cleaning applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021911702/en/ Photo credit: IFF This collaboration brings together two industry leaders with a shared vision: to develop high-performance, sustainable solutions that meet evolving consumer and market demands. By combining advanced chemical capabilities and expertise in biotechnology and protein engineering from IFF and BASF, the partnership aims to deliver breakthrough solutions at scale that enhance cleaning performance, imp

Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule21.10.2025 11:12:00 CEST | Press release

This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and pharmacokinetics of FNP-223 (oral formulation) in slowing the progression of progressive supranuclear palsy (PSP)The study is being conducted across 44 centers in the European Union, the United Kingdom, and the United StatesThe study reinforces Ferrer’s commitment to researching and developing transformative therapeutic solutions for people with rare neurological diseases Spanish international pharmaceutical company Ferrer has announced the completion of patient recruitment for the PROSPER study, a Phase II clinical trial designed to assess the efficacy, safety, and pharmacokinetics of FNP-223, an orally available, potent and selective inhibitor of the OGA enzyme, in-licensed from Asceneuron, aimed at slowing disease progression in Progressive Supranuclear Palsy (PSP)1. This press release features multimedia. View the full release here: https://www.businesswire.

Polpharma Biologics announces commercial launch of Europe’s first Pre-filled Syringe presentation of a ranibizumab biosimilar21.10.2025 10:51:00 CEST | Press release

Polpharma Biologics today announced Ranivisio® PFS (ranibizumab biosimilar pre-filled syringe), is now commercially available in France. Ranivisio® is the first Lucentis® biosimilar which is offered in a convenient pre-filled syringe (PFS) presentation in Europe, setting a new standard for affordable biologics in ophthalmic care. This innovative configuration provides precise dosing and ease of use, supporting efficient administration for patients with neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). Bioeq AG, a joint venture between Polpharma Biologics Group BV and Formycon AG, is responsible for the development and licensing of Ranivisio® PFS. Teva holds the commercialization rights for France under an exclusive licensing agreement with Bioeq. The drug substance for Ranivisio® PFS is manufactured by Polpharma Biologics S.A. - a contract development and manufacturing organization (CDMO) operating under the Rezon

Impartner Expands European Infrastructure to Accelerate Growth and Customer Support Across EMEA21.10.2025 10:00:00 CEST | Press release

Investment in European infrastructure strengthens Impartner’s EMEA operations and commitment to data security and regional growth Impartner, the leading provider of Partner Relationship Management (PRM) solutions, today announced the expansion of its European infrastructure with a new Azure-based data centre in the Netherlands. This milestone reflects Impartner’s accelerating success across the EMEA region and its commitment to providing customers with the highest levels of security, compliance, performance and support. “Our EMEA business continues to grow rapidly as companies across the region look to Impartner to scale their partner ecosystems,” said Curtis Brinkerhoff, CRO of Impartner. “Expanding our infrastructure within Europe, in close collaboration with Microsoft, ensures we are not only meeting strict EU data residency and privacy standards, but also strengthening performance and responsiveness for our customers across all industries.” By hosting in Microsoft’s Netherlands Azu

NTT DATA Strengthens Global Insurance Leadership with Acquisition of Alchemy Technology Services21.10.2025 10:00:00 CEST | Press release

NTT DATA, a global leader in AI, digital business and technology services, today announced the acquisition of Alchemy Technology Services, a specialist insurance technology consultancy. The move reinforces NTT DATA’s commitment to transforming the global insurance ecosystem, addressing current and emerging challenges around agility, modernization and scalability. In addition to its strong consultancy and Guidewire credentials, Alchemy brings deep expertise in the specialty insurance market, particularly in supporting complex and regulated environments, such as the London Market, the largest (re)insurance subscription market globally. This will further strengthen NTT DATA’s ability to serve niche and high-value segments across the global insurance landscape. A shared vision for insurance innovation This acquisition marks a significant milestone in NTT DATA’s strategy to lead the digital reinvention of the insurance sector - a market set to reach $230.7 billion in IT spend this year. Bui

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye